Stock CNSP CNS PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. CNS Pharmaceuticals, Inc.

Equities

CNSP

US18978H2013

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
0.204 USD -4.67% Intraday chart for CNS Pharmaceuticals, Inc. 0.00% -83.94%
Apr. 23 Transcript : CNS Pharmaceuticals, Inc. - Special Call
Apr. 01 CNS Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Maxim Downgrades CNS Pharmaceuticals to Hold From Buy
MT
CNS PHARMACEUTICALS : Brookline Capital Initiates Coverage on CNS Pharmaceuticals at Buy Rating, Sets Price Target at $10
MT
CNS PHARMACEUTICALS : Ladenburg Thalmann Downgrades CNS Pharmaceuticals to Neutral From Buy
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CNSP Stock
  4. News CNS Pharmaceuticals, Inc.
  5. Analyst Reco.